FibroBiologics, Inc.FBLG
Price (close)
$1.36
Market cap
$9.1M
P/E
—
Revenue (TTM)
—
Net income
-$18.1M
Dividend yield
—
1-year total return
-87.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What FibroBiologics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | — | -$5.1M | -$16.5M | -$11.2M | -$18.6M |
| Free cash flow | — | — | -$6.9M | -$12.1M | -$16.7M |
More on FBLG.
- FibroBiologics, Inc. summary
- FibroBiologics, Inc. financial statements
- FibroBiologics, Inc. key metrics
- FibroBiologics, Inc. health scores and style box
- FibroBiologics, Inc. earnings
- FibroBiologics, Inc. dividends
- FibroBiologics, Inc. valuation
- FibroBiologics, Inc. ownership and insiders
- FibroBiologics, Inc. peers
Figures from FibroBiologics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.